Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor activator. This innovative treatment holds significant potential for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide enhances insulin secretion and reduces glucagon release, leading to improved glucose control. Clinical trials have demo